Therapeutic angiogenesis inhibitors in the treatment of cancer

Adv Intern Med. 2001:47:159-90.
No abstract available

Publication types

  • Review

MeSH terms

  • 2-Methoxyestradiol
  • Angiogenesis Inhibitors / therapeutic use*
  • Antibodies, Monoclonal / therapeutic use
  • Antineoplastic Agents / therapeutic use
  • Collagen / therapeutic use
  • Endostatins
  • Endothelial Growth Factors / immunology
  • Enzyme Inhibitors / therapeutic use
  • Estradiol / analogs & derivatives*
  • Estradiol / therapeutic use
  • Humans
  • Hydroxamic Acids / therapeutic use
  • Lymphokines / immunology
  • Matrix Metalloproteinase Inhibitors
  • Neoplasms / drug therapy*
  • Organic Chemicals*
  • Peptide Fragments / therapeutic use
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Thalidomide / therapeutic use
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Endostatins
  • Endothelial Growth Factors
  • Enzyme Inhibitors
  • Hydroxamic Acids
  • Lymphokines
  • Matrix Metalloproteinase Inhibitors
  • Organic Chemicals
  • Peptide Fragments
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors
  • prinomastat
  • Estradiol
  • Thalidomide
  • 2-Methoxyestradiol
  • Collagen
  • marimastat
  • Protein-Tyrosine Kinases